BrUOG 390: Neoadjuvant Treatment With Talazoparib

Clinical trial NCT04598321 · TERMINATED

Trial details

NCT number: NCT04598321
Sponsor: Brown University
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

BRCA1 Mutation BRCA2 Mutation Ovarian Cancer Fallopian Tube Cancer High Grade Serous Carcinoma

Start date: 2021-03-29
Primary completion: 2022-11-30
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.